Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-15

Clinical Trial Update: A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Zidovudine/Lamivudine with Nevirapine or Nelfinavir to reduce HIV transmission from mother to child during breastfeeding; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epivir (Lamivudine)
  • RETROVIR (Zidovudine)
  • Viracept (Nelfinavir)
  • Viramune (Nevirapine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections | Phase 2 | Status: COMPLETED